Company · founded 1991
BioScience Laboratories (United States)
Bozeman, United States · biosciencelabs.com
- Citations, last 5 years
- 9
- Works, last 5 years
- 4
- h-index
- 37
- Scientists listed
- 0
- Grants since 2016
- 188
Grants received
2018–2019 · contract · N01
Support for Enhancing Study Drug Adherence in HIV Prevention Trials
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
CHARACTERIZATION OF THE PHARMACOKINETIC PROFILE OF A CANDIDATE HIV PREVENTION DRUG IN RHESUS MACAQUES
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2018–2027 · contract · N01
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
SUPPORT FOR ENHANCING STUDY DRUG ADHERENCE IN HIV PREVENTION TRIALS
Glen Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
2018–2028 · contract · N01
1800009I ADVANCED BIOSCIENCE LABORATORIES, INC.; TO V4 PIPB--1 BASE TASK ORDER FUNDING; IID CAN 8470036 $173,773
Tmothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2018–2020 · contract · N01
PRECLINICAL GAP-FILLING SERVICES: STUDIES TO ASSESS INTERACTIONS BETWEEN DAPIVIRINE AND VAGINALLY-APPLIED, OVER-THE-COUNTER PRODUCTS
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
Statistical Support for HIV Non-vaccine Biomedical Prevention Product Development
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2018–2021 · contract · N01
Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques
Maria Grazia Ferrari · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
ESSENTIAL CORE ACTIVITIES, NIAID PRECLINICAL DEVELOPMENT SUPPORT
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2025 · contract · N01
Production of Adjuvants
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
STUDIES TO ASSESS SHEEP VAGINAL MICROBIOME COMMUNITY PROFILES AND VAGINAL HEALTH
Glen Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2019 · contract · N01
Studies to Assess Sheep Vaginal Microbiome Community Profiles and Vaginal Health
Glen Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
Transcriptomics of RhCMV/SIV Vector-Vaccinated Macaques
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
Evaluation of the Immunogenicity and Efficacy of a DNA Prime/Protein Boost Vaccine
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
TASK A1: Product Development Plan for Cholera Product
Sandalon Ziv · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
Ovine Model and Vaginal Microbiome Support for HIV Non-vaccine Biomedical Prevention Product Development
Glenn Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT: Essential Core Activities
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
Essential Core Activities: NIAID Preclinical Development Support
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
Production of Aluminum Based Adjuvants
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2026 · contract · N01
Production of Aluminum Based Adjuvants
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT: Essential Core Activities
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
Long Term Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
Timothy R Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2020 · contract · N01
Evaluation of Immune Responses to a Trimerically Stabilized gp120 Immunogen
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
NONHUMAN PRIMATE PURCHASE AND HOLDING
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2020 · contract · N01
NIAID Preclinical Development Support
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
DEVELOPMENT OF HIV NON-VACCINE BIOMEDICAL PREVENTION PRODUCTS: PRODUCT ATTRIBUTES, POSITIONING, AND MESSAGING TO DRIVE ADOPTION AND USE OF NEW PERSONAL USE PRODUCTS
Glen Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Engineering Hair Follicles in Vascularized 3D Skin Models
Angela M Christiano · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
Development of HIV Non-Vaccine Biomedical Prevention Products: Product Attributes, Positioning, and Messaging to Drive Adoption and Use of New Personal Use Products
Glen Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
cGMP Production of HIV-1 Envelope (Env) Bulk Harvest
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
Production of Aluminum Based Adjuvants
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2025 · contract · N01
Production of Adjuvants
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
NIAID Preclinical Development Support
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
Fill-Finish, Release, and Stability Testing of HIV-1 gp120 Proteins
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2017–2026 · contract · N01
Production of Aluminum Based Adjuvants
Fred Mack · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy Following Mucosal Virus Challenge
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2022 · contract · N01
Task X19: GMP Manufacturing for a Malaria Vaccine
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
IGF::OT::IGF PLANNING AND IMPLEMENTATION OF A NIAID CONSULTATION: ADVANCING DEVELOPMENT OF MULTIPURPOSE PREVENTION TECHNOLOGIES (MPT).
Glenn Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
